8-K: Cross Country Healthcare Stockholders Approve Merger Agreement

Cross Country Healthcare's stockholders have overwhelmingly approved the merger agreement with KL Criss Cross Intermediate, LLC, paving the way for the company to be delisted from NASDAQ.

Summary

• Cross Country Healthcare, Inc. held a special meeting of stockholders on July 16, 2026, to vote on proposals related to a merger agreement.
• The merger agreement, dated May 6, 2026, involves KL Criss Cross Intermediate, LLC and its subsidiary KL Criss Cross Merger Sub, Inc.
• Upon completion, Cross Country Healthcare will become a wholly-owned subsidiary of Parent, and its common stock will be delisted from NASDAQ.
• A quorum of 72.36% of outstanding shares was present, with 23,378,853 shares represented.
• Stockholders approved the Merger Agreement Proposal (Proposal 1) and the Advisory Merger-Related Compensation Proposal (Proposal 2).
• Proposal 1 received 23,356,105 'For' votes, 12,309 'Against' votes, and 10,439 'Abstentions'.
• Proposal 2 received 20,281,587 'For' votes, 1,855,191 'Against' votes, and 1,242,075 'Abstentions'.
• The Adjournment Proposal (Proposal 3) was not necessary due to sufficient votes for the merger.
• The merger is expected to close in the third quarter of 2026, subject to customary closing conditions and regulatory approvals.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development, as the overwhelming stockholder approval of the merger agreement indicates strong support for the transaction and its expected benefits, despite some concerns regarding executive compensation.

Positives

• Strong stockholder approval for the merger agreement, with a significant majority voting in favor of Proposal 1 (23,356,105 'For' votes).
• High turnout at the special meeting, with 72.36% of outstanding shares represented, indicating strong stakeholder engagement.
• Approval of the merger-related compensation proposal suggests alignment between management and stockholders on executive compensation in the context of the transaction.

Negatives

• A small number of 'Against' votes (12,309) on the Merger Agreement Proposal indicates some dissent among stockholders.
• A notable number of 'Against' votes (1,855,191) and abstentions (1,242,075) on the Advisory Merger-Related Compensation Proposal suggest potential concerns regarding executive pay.

Risks

• The merger is subject to the satisfaction or waiver of customary closing conditions, including receipt of certain regulatory approvals.
• There is a risk that a condition of closing may not be satisfied or that the closing may not otherwise occur.
• Regulatory approvals required for the merger may not be obtained or may be obtained subject to unanticipated conditions.
• Management time may be diverted from ongoing business operations due to transaction-related issues.
• Announcements relating to the proposed merger could have adverse effects on the market price of Company Common Shares.
• The merger and its announcement could adversely affect the Company's ability to retain customers, key personnel, and maintain relationships with suppliers and customers.
• There is a risk of termination of the Merger Agreement, potentially requiring the Company to pay a termination fee.
• Competing offers for the company could emerge.

Future Outlook

The merger is expected to close in the third quarter of 2026, subject to the satisfaction or waiver of customary closing conditions, including receipt of certain regulatory approvals. Following the merger, the Company's common stock will be delisted from the NASDAQ Stock Market LLC and deregistered under the Securities Exchange Act of 1934.

Management Comments

• The company's common stock will be delisted from the NASDAQ Stock Market LLC and deregistered under the Securities Exchange Act of 1934, as amended, in connection with closing the Merger.

Industry Context

StockSavvy.ai notes that the approval of this merger by Cross Country Healthcare's stockholders is a significant step towards its privatization. This aligns with a broader trend in the healthcare staffing industry where consolidation continues, driven by the need for scale, efficiency, and specialized services in a dynamic market.

Legal Proceedings

• Potential litigation relating to the Merger that could be instituted against the parties to the Merger Agreement or their respective directors, managers, or officers.

Stakeholder Impact

• Shareholders: The merger will result in the Company no longer being publicly held, with common stock delisted from NASDAQ. Stockholders approved the merger and related compensation.
• Employees: Potential risks include disruption of management time from ongoing business operations and adverse effects on the ability to retain key personnel.
• Customers and Suppliers: Risks include adverse effects on the ability to maintain relationships with customers and suppliers.

Next Steps

• Closing the Merger, subject to the satisfaction or waiver of customary closing conditions, including receipt of certain regulatory approvals.
• Delisting of the Company's common stock from the NASDAQ Stock Market LLC.
• Deregistration of the Company's common stock under the Securities Exchange Act of 1934.

Key Dates

Recommendation

The filing confirms stockholder approval for the merger, which is a significant step towards privatization. While the approval is strong, the ongoing risks associated with closing conditions, regulatory approvals, and potential litigation, along with some concerns raised about executive compensation, warrant a 'hold' recommendation pending further clarity on the closing process and post-merger integration.

Keywords

Merger Agreement, Stockholder Vote, Cross Country Healthcare, Special Meeting, Delisting, NASDAQ, Regulatory Approval, Corporate Governance